S&P 500

5.321,41

0,25%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Organovo Holdings Inc (ONVO)
Organovo Holdings Inc (ONVO) Notícias

ONVO

Organovo (ONVO)

Organovo Holdings Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ONVO

1 2 3 4 5 6 7 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
21/05/2024	09:05	GlobeNewswire Inc.	Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease	NASDAQ:ONVO	Organovo Holdings Inc
14/05/2024	13:45	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:ONVO	Organovo Holdings Inc
14/05/2024	12:00	GlobeNewswire Inc.	Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)	NASDAQ:ONVO	Organovo Holdings Inc
13/05/2024	18:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ONVO	Organovo Holdings Inc
08/05/2024	21:00	GlobeNewswire Inc.	Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering	NASDAQ:ONVO	Organovo Holdings Inc
15/04/2024	09:05	GlobeNewswire Inc.	Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo	NASDAQ:ONVO	Organovo Holdings Inc
09/02/2024	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ONVO	Organovo Holdings Inc
08/02/2024	18:56	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ONVO	Organovo Holdings Inc
08/02/2024	18:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ONVO	Organovo Holdings Inc
26/01/2024	19:09	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ONVO	Organovo Holdings Inc
25/01/2024	10:05	GlobeNewswire Inc.	Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress	NASDAQ:ONVO	Organovo Holdings Inc
09/01/2024	10:05	GlobeNewswire Inc.	Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress	NASDAQ:ONVO	Organovo Holdings Inc
06/12/2023	10:05	GlobeNewswire Inc.	Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results	NASDAQ:ONVO	Organovo Holdings Inc
01/12/2023	18:07	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ONVO	Organovo Holdings Inc
17/11/2023	20:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ONVO	Organovo Holdings Inc
15/11/2023	18:41	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ONVO	Organovo Holdings Inc
13/11/2023	10:05	GlobeNewswire Inc.	CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan	NASDAQ:ONVO	Organovo Holdings Inc
08/11/2023	10:05	GlobeNewswire Inc.	Organovo Highlights FXR314 Combination Therapy Potential and Plan	NASDAQ:ONVO	Organovo Holdings Inc
22/09/2023	17:05	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:ONVO	Organovo Holdings Inc
13/09/2023	18:07	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ONVO	Organovo Holdings Inc
13/09/2023	18:06	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ONVO	Organovo Holdings Inc
13/09/2023	18:06	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ONVO	Organovo Holdings Inc
08/09/2023	13:46	GlobeNewswire Inc.	Organovo to Participate in the H.C. Wainwright Global Investment Conference	NASDAQ:ONVO	Organovo Holdings Inc
23/08/2023	09:05	GlobeNewswire Inc.	Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data	NASDAQ:ONVO	Organovo Holdings Inc
31/07/2023	17:05	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:ONVO	Organovo Holdings Inc
14/07/2023	18:05	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:ONVO	Organovo Holdings Inc
29/06/2023	17:07	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	NASDAQ:ONVO	Organovo Holdings Inc
29/06/2023	17:06	Edgar (US Regulatory)	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405	NASDAQ:ONVO	Organovo Holdings Inc
21/03/2023	09:05	GlobeNewswire Inc.	Organovo Announces FXR Program	NASDAQ:ONVO	Organovo Holdings Inc
15/03/2023	18:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ONVO	Organovo Holdings Inc